Clinical Trial Update: Prevention of Disease Progress in Chronic Hepatitis C Patients With Liver Fibrosis (Study P02570AM2)(COMPLETED) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing prevention of disease progression in chronic hepatitis C patients with liver fibrosis has completed and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Fibrosis

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Hepatitis C, Liver Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2011-01-20